))
ART Doesn’t Increase Hormone Receptor-Positive Breast Cancer Recurrence Risk
Manage episode 388173608 series 3525104
Kandungan disediakan oleh Breastcancer.org. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Breastcancer.org atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
At the 2023 San Antonio Breast Cancer Symposium, Dr. Hatem Azim presented a new analysis of information from the POSITIVE trial, which found that younger women diagnosed with early-stage, hormone receptor-positive breast cancer could safely pause hormonal therapy to try to become pregnant. His new analysis looked at whether the women could use fertility preservation and assisted reproductive technologies (ART) without increasing the risk of the cancer coming back (recurrence).
Listen to the podcast to hear Dr. Azim discuss:
- the types of fertility preservation and ART used
- which techniques were the most successful
- the results of his analysis
303 episod
Kongsi
